Journal Of Kidney Cancer And Vhl

The Journal of Kidney Cancer and VHL is a peer-reviewed online open access journal that focuses on disseminating research findings on kidney cancer and Von Hippel Lindau disease. Renal cell carcinoma, also known as renal cell carcinoma, accounts for approximately 2% of all cancers, and abnormalities in the VHL gene are the main risk factor for the development of renal cell carcinoma. VHL abnormalities can also lead to another rare disease, VHL syndrome, whose incidence rate is estimated to be 1/36000.

This journal aims to become an academic forum for academic exchange, enabling scientists to develop better treatment strategies for these two diseases. The Journal of Kidney Cancer and VHL publishes basic scientific and clinical research articles on all aspects of kidney cancer and VHL, including original articles, reviews, case reports, brief communications, and letters to editors, and is suitable for submission.

《肾癌与VHL杂志》是一本同行评审的在线开放获取期刊，专注于传播肾癌和VHL（Von Hippel-Lindau）疾病的研究成果。肾癌，也称为肾细胞癌，约占所有癌症的2%，而VHL基因的异常是肾癌发展的主要风险因素。VHL异常也会导致另一种罕见病——VHL综合征，其发病率估计为1/36000 。

该期刊旨在成为一个学术交流的学术论坛，使科学家能够为这两种疾病开发更好的治疗策略。《肾癌与VHL杂志》发表关于肾癌和VHL的所有方面的基础科学和临床研究文章，包括原创文章、综述、病例报告、简短通讯和给编辑的信件等类型的文章，适合提交 。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映ONCOLOGY领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为1.9，平均审稿速度为 4 Weeks ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。